Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
